Rick Pearson is an activist investor focused on U.S. listed stocks in the U.S. and in China. He was previously an investment banker in one of Wall Street's largest investment banks for nearly a decade, stationed between New York, Hong Kong and London. As a director in equity capital markets he oversaw over $30 billion in equity and equity linked transactions, primarily for health care and technology companies.
Pearson spends his time living between Los Angeles and Beijing. He has a degree in finance from the University of Southern California and has studied Mandarin since 1991.
Individual company fundamentals are now taking a back seat to overall market sentiment in determining stock prices, creating an opportunity to occasionally pick up value stocks on the cheap.
Despite tremendous profitability and a listing on the New York Stock Exchange, Duoyuan Printing has traded down to where its P/E is only 6.5 times trailing earnings.
The potential uplisting of Biostar has created some misconceptions about how a stock makes its way to a major exchange.
Rick Pearson is focusing on New Energy Systems and Biostar Pharmaceutical as he sees them uplisting soon.
Biostar has recently applied for a Nasdaq listing and could be a double or triple once it trades on the Nasdaq.
New Energy Systems will soon release annual results that contain non-cash charges related to share issuances and acquisitions. There are two reasons I will ignore those charges.
Not since the blazing days of the Internet boom have I seen a more deserving candidate for a 'strong sell' recommendation.
There are certain guidelines to be followed when investing in China small-caps.
China Carbon Graphite looks as if could be a three-bagger if it can get uplisted by Nasdaq and earn $6 million in 2010.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.